Founded in 2006, Beacon Pharmaceutical Limited is Bangladesh's largest pharmaceutical firm in oncology, currently headquartered in the country's capital Dhaka. Beacon Pharmaceuticals Limited aims to become a global firm that can meet the world's greatest health needs. Since its founding, Beacon has been dedicated to researching and developing new treatments for cancer and few other life-threatening illnesses. Beacon is the first pharmaceutical company in Bangladesh to produce cancer medications.

Developed by European specialists, Beacon boasts one of the best infrastructure and facilities in the industry. The facilities are equipped with the most modern equipment to comply with international standards such as the US-FDA, UK-MHRA, TGA-Australia, and WHO-cGMP. Beacon Pharmaceuticals produce over 200 generic medications and 65 cancer products. Beacon introduces more than 15 new high-tech items per year. In addition, Beacon's R&D team has released several new generic drugs that have made Beacon Pharma shine in the global pharmaceutical industry.

Beacon, a company that employs a total of 2000 employees, is listed as a public limited company in both Dhaka and Chittagong Stock Exchanges.

Beacon exports its pharmaceuticals to various nations in Asia, Africa, Europe, and Latin America after satisfying the local demand.